ANN ARBOR, Mich., June 15 /PRNewswire-FirstCall/ — Adeona
Pharmaceuticals, Inc. (Amex: AEN) announced that its wholly-owned
CLIA-certified clinical testing subsidiary, HartLab, has expanded
its in-house diagnostic testing services to include a full array of
microbiology testing. Adeona believes that that this
expansion of services will be accretive to HartLab’s revenues in
the current quarter and beyond and is consistent with Adeona’s
plans to continue to build the revenues of its HartLab
subsidiary.
Microbiology testing includes a broad array of tests for the
identification and sensitivity testing of the causative agents of
infectious diseases followed by prompt, accurate reporting of
results. HartLab has the ability to develop and implement new
culture techniques, immunoassays, and molecular methods for rapid
detection and identification of common as well as unusual microbial
pathogens. Serologic testing is also available for confirmation of
infections by demonstrating the presence of specific antibody
responses.
As part of its new microbiology department, HartLab has hired
Mariana Badescu, MD, PhD, as
Technical Supervisor and Mihai
Badescu, BS, MA, M(ASCP), as Lead Microbiology Technologist.
Dr. Badescu, a certified Specialist in Microbiology and Public
Health, comes to HartLab with over 20 years of microbiology
laboratory experience and infection control.
“Offering our clients a comprehensive array of clinical testing
services under one roof has been a long-term goal for us,” said
Lisa Jo Abbo, Vice President of
HartLab. “We are glad we can add further value to the relationships
we h
‘/>”/>
SOURCE
